Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B-Cell–Depleting Therapy With COVID-19: A Target Trial Emulation Study
- Journal:
- Clinical Infectious Diseases
- Published:
- DOI:
- 10.1093/cid/ciaf521
- Affiliations:
- 5
- Authors:
- 9
| Institutions | Authors | Share |
|---|---|---|
| Cleveland Clinic, United States of America (USA) | 0.94 | |
| Cleveland State University, United States of America (USA) | 0.06 |